Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars
罗切斯特合作伙伴关系促进聋人学者的研究和学术生涯
基本信息
- 批准号:9895820
- 负责人:
- 金额:$ 48.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAreaAttitudeBehavioralBehavioral SciencesClinical SciencesCollaborationsCompetenceDevelopment PlansDoctor of PhilosophyEducationEducational process of instructingEvaluationFacultyGoalsHealthHearingIndividualInstitutesInstitutionKnowledgeLeadershipMeasuresMentorsNCI Scholars ProgramOutcomePerformancePersonsPostdoctoral FellowResearchRoleScienceScientistStudentsTechnologyTimeTrainingTranslational ResearchUniversitiescareercareer developmentcultural competencedeafeffectiveness measureexperiencehard of hearinginnovationinter-institutionalnovelprogramsrecruitskillssuccess
项目摘要
DESCRIPTION (provided by applicant): The overall goals of the Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars are: a) to provide highly trained biomedical and behavioral scientists who are Deaf and Hard-of-Hearing (D/HH) with the knowledge and skills to pursue research and teaching careers in academia; and b) to partner the faculty and programs of the University of Rochester (UR), including its National Center for Deaf Health Research (NCDHR) and Clinical and Translational Science Institute (CTSI), with those of the Rochester Institute of Technology (RIT), including its National Technical Institute fo the Deaf (NTID), with the long term objective of promoting linkages between the partners and strengthening their excellence in research and education. The program has four specific aims: 1) To develop a mentored postdoctoral research experience for D/HH biomedical and behavioral PhD Scholars at the UR, a research-intensive institution. To do this, we will leverage the well-developed Mentor-Scholar Program established by the UR CTSI, to provide interdisciplinary team mentoring and to define and meet career development goals for each Scholar, as set forth in their Individual Development Plan. We will also take advantage of the CTSI's novel "Mentor the Mentor" Program, and will enhance this program to increase the D/HH cultural competency of UR faculty, and their ability to effectively mentor D/HH Scholars; 2) To establish career development activities at UR and a mentored practicum teaching experience at NTID/RIT to develop the academic and teaching skills of program Scholars, and to strengthen and expand educational offerings at RIT in the areas of biomedical and behavioral science; 3) To evaluate program success, by measuring the effectiveness of training in both research and teaching. This will include assessment of short-term objectives and acquired competencies related to teaching and research skills, knowledge and attitudes; and evaluation of long-term career development and academic performance outcomes related to teaching and research. We will also measure the impact of the program on: the diversity of science educational offerings at RIT; entry by D/HH students into biomedically-related and behavioral science majors and programs at RIT; research collaborations between RIT and UR; and 4) To recruit 3 Scholars from a national pool of D/HH persons with biomedical and behavioral doctorates for 3-year periods of training, for a steady state of 9 D/HH Scholars at any one time. This recruitment will build on prior experience of recruiting D/HH postdoctoral fellows to UR, NTID's leadership role in the national networks that promote postsecondary education and career development in D/HH students, and the global reputation of Rochester, NY as a center for D/HH culture and education. This innovative inter-institutional partnership is the first of its kind in the world an will begin to address the dearth of D/HH faculty at academic institutions serving both hearing and D/HH students. A long-term outcome will be the attraction of more D/HH Scholars into careers in the biomedical and behavioral sciences, fields in which D/HH persons are greatly under-represented.
描述(由申请人提供):罗切斯特合作伙伴关系的总体目标,以提高聋人学者的研究和学术职业为:a)提供训练有素的生物医学和行为科学家,他们是聋哑人,聋哑人(D/HH),具有知识和技能,以从事学术界从事研究和教学职业的知识和技能;和b)与罗切斯特大学(UN)的教职员工和课程合作,包括其国家聋人健康研究中心(NCDHR)和临床和转化科学研究所(CTSI),以及罗切斯特技术学院(RIT)的教职员工(CTSI),包括其国家技术研究所(NTID)的国家技术研究所(NTID),包括聋哑人(NTID)的教育,并在促进的教育方面进行了良好的教育和良好的良好态度,并促进了良好的良好和良好的良好和优势。该计划具有四个具体的目标:1)在UR(这是一个研究密集型机构UR)中,为D/HH生物医学和行为博士学位学者开发指导的博士后研究经验。为此,我们将利用Ur CTSI建立的发达的导师 - 智术计划,以提供跨学科的团队指导,并定义和实现每个学者的职业发展目标,如其个人发展计划中所述。我们还将利用CTSI的小说“导师导师”计划,并将增强该计划以提高UR教师的D/HH文化能力,以及它们有效指导D/HH学者的能力; 2)在UR上建立职业发展活动,并在NTID/RIT的指导实践教学经验,以发展计划学者的学术和教学技能,并在生物医学和行为科学领域加强RIT的RIT和扩展教育产品; 3)通过衡量培训在研究和教学中的有效性来评估计划的成功。这将包括评估与教学和研究技能,知识和态度有关的短期目标和获得的能力;并评估与教学和研究有关的长期职业发展和学习成绩。我们还将衡量该计划对:RIT科学教育产品的多样性; D/HH学生进入RIT的生物医学相关和行为科学专业和计划; RIT与UR之间的研究合作;和4)从一组为生物医学和行为博士学位的D/HH的国家组成3年培训的国家库中招募3名学者,但一次稳定的稳定状态为9 d/hh学者。这项招聘将基于先前招募D/HH博士后研究员的经验,即NTID在促进D/HH学生中专上教育和职业发展的国家网络中的领导作用,以及纽约州罗切斯特的全球声誉,是D/HH文化和教育的中心。这种创新的机构间合作伙伴关系是世界上第一个同类伙伴关系,这将开始解决D/HH教职员工的缺乏,该学术机构为听力和D/HH学生提供服务。长期的结果将吸引更多的D/HH学者参与生物医学和行为科学的职业,其中D/HH人的代表性大大不足。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Dewhurst其他文献
Stephen Dewhurst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Dewhurst', 18)}}的其他基金
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilities
COV-IDD:对患有智力和发育障碍的高危儿童进行 COVID-19 检测
- 批准号:
10371509 - 财政年份:2021
- 资助金额:
$ 48.08万 - 项目类别:
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilities
COV-IDD:对患有智力和发育障碍的高危儿童进行 COVID-19 检测
- 批准号:
10569140 - 财政年份:2021
- 资助金额:
$ 48.08万 - 项目类别:
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars
罗切斯特合作伙伴关系促进聋人学者的研究和学术生涯
- 批准号:
8751868 - 财政年份:2015
- 资助金额:
$ 48.08万 - 项目类别:
Rochester Partnership to Advance Research and Academic Careers in Deaf Scholars
罗切斯特合作伙伴关系促进聋人学者的研究和学术生涯
- 批准号:
9090192 - 财政年份:2015
- 资助金额:
$ 48.08万 - 项目类别:
Enhanced Live Attenuated Influenza Virus With Improved Safety and Immunogenicity
增强型减毒活流感病毒,具有更高的安全性和免疫原性
- 批准号:
8883370 - 财政年份:2014
- 资助金额:
$ 48.08万 - 项目类别:
URBEST: The University of Rochester BEST Training Program
URBEST:罗彻斯特大学 BEST 培训计划
- 批准号:
8929332 - 财政年份:2014
- 资助金额:
$ 48.08万 - 项目类别:
The Semen Enhancer of HIV Infection as a Novel Microbicide Target
HIV 感染的精液增强剂作为新型杀菌剂靶标
- 批准号:
8650498 - 财政年份:2011
- 资助金额:
$ 48.08万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 48.08万 - 项目类别:
San Diego State University Advancing Cancer Careers for ExceLlence (ACCEL)
圣地亚哥州立大学卓越推进癌症职业 (ACCEL)
- 批准号:
10784133 - 财政年份:2023
- 资助金额:
$ 48.08万 - 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 48.08万 - 项目类别:
2023 RNA Nanotechnology Gordon Research Conference and Seminar
2023年RNA纳米技术戈登研究会议暨研讨会
- 批准号:
10598881 - 财政年份:2023
- 资助金额:
$ 48.08万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 48.08万 - 项目类别: